Clinical Trial Update: Study Investigating the Role of Oxaliplatin Duration in Modified FOLFOX-6 or CAPOX Regimen as Adjuvant Colon Cancer Therapy [Phase 3]

View source ↗

Summary

Phase 3 study investigating oxaliplatin duration in modified FOLFOX-6 or CAPOX as adjuvant therapy for colon cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• CAPOX (capecitabine + oxaliplatin)
• FOLFOX-6
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Samsung Medical Center | Conditions: Colon Cancer | Phase 3 | Status: UNKNOWN